News Coverage 03.10.20 Share on Twitter Share on Facebook Share on LinkedIn CRISPR-edited immune cells can survive and thrive after infusion into cancer patients Related Announcement, Our Impact PICI-Founded Dispatch Bio Takes on Solid Tumors Announcement CNBC Honors Dr. Karen Knudsen, PICI CEO, as Changemaker Research Update Data to Design: Inside Our Spring Scientific Retreat